Register to download the report

Bouygues leads overall QoE in France. Orange stands out in Data & OTT and speed. Free pushes 5G SA.

What’s inside:

• QoE ranking and Mobile Experience Awards (France – Q3 2025)

• Real-world performance for speed, latency, streaming, social media and gaming

• Insights on 5G SA and the gap between 5G availability

• Actionable takeaways for operators, regulators and media

Our France 5G QoE benchmarking reveals clear differences in real network experience—where some operators consistently deliver on 5G expectations, while others still lag in key service moments.

Upon approval of your request, you will receive a confirmation email with a secure download link. Please note that a valid work email address is required to access the report. If your request is incomplete, we may ask you to review and update your details accordingly.

MedUX is committed to recurring country-level 5G benchmarking campaigns across Europe and is actively working towards enabling continuous, 24/7 QoE monitoring in select geographies on demand. If you are interested in exclusive insights or strategic collaborations in France, feel free to reach out to us at hello@medux.com.

In the meantime, we invite you to explore the details of our recent blog post and download a copy of our detailed report on the true 5G experience in Europe: “Europe’s 5G Progress: Are We Meeting Expectations?”

ALL RIGHTS RESERVED. This article or report has been prepared for the exclusive use and benefit of press media and solely for non-commercial purposes. Press media members are authorized to entirely or partially disseminate, refer, quote, copy, reproduce, distribute, publish and transfer the report and its findings (including all intellectual property rights, data, content graphs and analysis) for information purposes with express attribution to MedUX. Use of the report and its findings, entirely or partially, in any form or by any means, by any other third party or for any other purposes (including, commercial or marketing purposes), without the prior written consent of MedUX, is strictly prohibited. Operators can make a request to MedUX for a license to use quality or certification seals, as well as marketing rights to quote the findings. Non-authorized use will be considered a violation of copyright and trademarks laws.